Viswanathan VK - Search Results

1

Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.

Royan SV, Jones RM, Koutsouris A, Roxas JL, Falzari K, Weflen AW, Kim A, Bellmeyer A, Turner JR, Neish AS, Rhee KJ, Viswanathan VK, Hecht GA. Royan SV, et al. Among authors: viswanathan vk. Mol Microbiol. 2010 Dec;78(5):1232-45. doi: 10.1111/j.1365-2958.2010.07400.x. Epub 2010 Oct 15. Mol Microbiol. 2010. PMID: 21091507 Free PMC article.

2

Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation.

Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Berkes J, et al. Among authors: viswanathan vk. Gut. 2003 Mar;52(3):439-51. doi: 10.1136/gut.52.3.439. Gut. 2003. PMID: 12584232 Free PMC article. Review.

3

Microbes and their products--physiological effects upon mammalian mucosa.

Viswanathan VK, Sharma R, Hecht G. Viswanathan VK, et al. Adv Drug Deliv Rev. 2004 Apr 19;56(6):727-62. doi: 10.1016/j.addr.2003.09.005. Adv Drug Deliv Rev. 2004. PMID: 15063587 Review.

4

Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.

Viswanathan VK, Koutsouris A, Lukic S, Pilkinton M, Simonovic I, Simonovic M, Hecht G. Viswanathan VK, et al. Infect Immun. 2004 Jun;72(6):3218-27. doi: 10.1128/IAI.72.6.3218-3227.2004. Infect Immun. 2004. PMID: 15155623 Free PMC article.

5

Cytokeratin 18 interacts with the enteropathogenic Escherichia coli secreted protein F (EspF) and is redistributed after infection.

Viswanathan VK, Lukic S, Koutsouris A, Miao R, Muza MM, Hecht G. Viswanathan VK, et al. Cell Microbiol. 2004 Oct;6(10):987-97. doi: 10.1111/j.1462-5822.2004.00416.x. Cell Microbiol. 2004. PMID: 15339273

6

Differing roles of protein kinase C-zeta in disruption of tight junction barrier by enteropathogenic and enterohemorrhagic Escherichia coli.

Tomson FL, Koutsouris A, Viswanathan VK, Turner JR, Savkovic SD, Hecht G. Tomson FL, et al. Among authors: viswanathan vk. Gastroenterology. 2004 Sep;127(3):859-69. doi: 10.1053/j.gastro.2004.06.014. Gastroenterology. 2004. PMID: 15362041

7

Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier.

Tomson FL, Viswanathan VK, Kanack KJ, Kanteti RP, Straub KV, Menet M, Kaper JB, Hecht G. Tomson FL, et al. Among authors: viswanathan vk. Mol Microbiol. 2005 Apr;56(2):447-64. doi: 10.1111/j.1365-2958.2005.04571.x. Mol Microbiol. 2005. PMID: 15813736 Free article.

8

Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells.

Sharma R, Tesfay S, Tomson FL, Kanteti RP, Viswanathan VK, Hecht G. Sharma R, et al. Among authors: viswanathan vk. Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G685-94. doi: 10.1152/ajpgi.00404.2005. Epub 2005 Dec 1. Am J Physiol Gastrointest Liver Physiol. 2006. PMID: 16322091 Free article.

9

Innate immunity and the gut.

Viswanathan VK, Hecht G. Viswanathan VK, et al. Curr Opin Gastroenterol. 2000 Nov;16(6):546-51. doi: 10.1097/00001574-200011000-00015. Curr Opin Gastroenterol. 2000. PMID: 17031136

10

Enteropathogenic Escherichia coli-induced epidermal growth factor receptor activation contributes to physiological alterations in intestinal epithelial cells.

Roxas JL, Koutsouris A, Viswanathan VK. Roxas JL, et al. Among authors: viswanathan vk. Infect Immun. 2007 May;75(5):2316-24. doi: 10.1128/IAI.01690-06. Epub 2007 Mar 5. Infect Immun. 2007. PMID: 17339360 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters